Evidence map›Paper›PMID 21192864›Full record

ArticleEmerging infectious diseases2011

CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United States.

Maria Sjölund-Karlsson, Rebecca Howie, Amy Krueger, Regan Rickert, Gary Pecic, Kathryn Lupoli, Jason P Folster, Jean M Whichard

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetic Characterization ofFrontiers in microbiology · 2019
    Article
  11. The Emergence of Chromosomally LocatedFrontiers in microbiology · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Detection ofJournal of clinical and diagnostic research : JCDR · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria Sjölund-KarlssonNational Antimicrobial Resistance Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. fwt4@cdc.gov
Rebecca Howie
Amy Krueger
Regan Rickert
Gary Pecic
Kathryn Lupoli
Jason P Folster
Jean M Whichard

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CTX-M-type beta-lactamases are increasing among US Enterobacteriaceae isolates. Of 2,165 non-Typhi Salmonella isolates submitted in 2007 to the National Antimicrobial Resistance Monitoring System, 100 (4.6%) displayed elevated MICs (≥2 mg/L) of ceftriaxone or ceftiofur. Three isolates (serotypes Typhimurium, Concord, and I 4,5,12:i:-) contained bla(CTX-M-5), bla(CTX-M-15), and bla(CTX-M-55/57), respectively.

Indexed as

Anti-Bacterial Agentsbeta-Lactamasesbeta-Lactam ResistanceCeftriaxoneCephalosporin ResistanceCephalosporinsHumansInfantMicrobial Sensitivity TestsPopulation SurveillanceSalmonellaSalmonella InfectionsSalmonella typhimuriumSerotypingUnited StatesAnti-Bacterial Agentsbeta-lactamase CTX-M-15beta-LactamasesceftiofurCeftriaxoneCephalosporins

Identifiers

PMID21192864
PMCPMC3204627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.